← Dassault Systemes overview

Dassault Systemes vs Aurora Innovation: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Dassault Systemes SE (DSY.PA)

Q3 2026
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

August 2026
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

Latest
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

Aurora Innovation Inc (AUR)

Q3 2026
▲3

Aurora's driverless truck rollout accelerates, but 2030 targets and cash burn divide analysts

  • Second-gen driverless truck platform launches Aurora launched its second-generation driverless truck platform, cutting hardware costs by over half and tripling durability. New customer agreements with Value Truck and Charger Logistics followed. This lowers the cost to scale and signals real commercial demand, supporting the stock.

    It is the core new product and customer event that drives the rollout story.

  • Driverless commercial hauls begin with McLane and Hirschbach deal Aurora started driverless hauls for McLane and signed Hirschbach for 500 autonomous trucks starting 2027. These are real paying customers, not just tests, showing the business is moving from trials to commercial operations and boosting confidence in future revenue.

    It marks the shift from testing to paying commercial customers, a key demand signal.

  • Production ramp targets 20 trucks per week in Q4 Aurora aims to build 20 driverless trucks per week in Q4 and is fully allocated for 2026, with revenue guidance of $14–16 million. This shows the company can scale manufacturing, a key step toward its 200-truck year-end goal and future growth.

    It gives concrete evidence of manufacturing scale-up, which underpins the growth story.

  • Investor Day 2030 targets and analyst split Aurora set 2030 goals of 30,000 driverless trucks and $5 billion revenue at 60% gross margin, but pushed breakeven gross margin to H1 2027. Analysts' price targets range from $7 to $18, with Goldman cautious on a slower, costlier ramp. The long-term vision is huge, but near-term cash burn and execution risk keep the stock volatile.

    It captures both the ambitious long-term plan and the real counterweight of execution and cash concerns.

August 2026
▲3

Aurora's driverless truck rollout accelerates, but 2030 targets and cash burn divide analysts

  • Second-gen driverless truck platform launches Aurora launched its second-generation driverless truck platform, cutting hardware costs by over half and tripling durability. New customer agreements with Value Truck and Charger Logistics followed. This lowers the cost to scale and signals real commercial demand, supporting the stock.

    It is the core new product and customer event that drives the rollout story.

  • Driverless commercial hauls begin with McLane and Hirschbach deal Aurora started driverless hauls for McLane and signed Hirschbach for 500 autonomous trucks starting 2027. These are real paying customers, not just tests, showing the business is moving from trials to commercial operations and boosting confidence in future revenue.

    It marks the shift from testing to paying commercial customers, a key demand signal.

  • Production ramp targets 20 trucks per week in Q4 Aurora aims to build 20 driverless trucks per week in Q4 and is fully allocated for 2026, with revenue guidance of $14–16 million. This shows the company can scale manufacturing, a key step toward its 200-truck year-end goal and future growth.

    It gives concrete evidence of manufacturing scale-up, which underpins the growth story.

  • Investor Day 2030 targets and analyst split Aurora set 2030 goals of 30,000 driverless trucks and $5 billion revenue at 60% gross margin, but pushed breakeven gross margin to H1 2027. Analysts' price targets range from $7 to $18, with Goldman cautious on a slower, costlier ramp. The long-term vision is huge, but near-term cash burn and execution risk keep the stock volatile.

    It captures both the ambitious long-term plan and the real counterweight of execution and cash concerns.

Latest
▲3

Aurora's driverless truck rollout accelerates, but 2030 targets and cash burn divide analysts

  • Second-gen driverless truck platform launches Aurora launched its second-generation driverless truck platform, cutting hardware costs by over half and tripling durability. New customer agreements with Value Truck and Charger Logistics followed. This lowers the cost to scale and signals real commercial demand, supporting the stock.

    It is the core new product and customer event that drives the rollout story.

  • Driverless commercial hauls begin with McLane and Hirschbach deal Aurora started driverless hauls for McLane and signed Hirschbach for 500 autonomous trucks starting 2027. These are real paying customers, not just tests, showing the business is moving from trials to commercial operations and boosting confidence in future revenue.

    It marks the shift from testing to paying commercial customers, a key demand signal.

  • Production ramp targets 20 trucks per week in Q4 Aurora aims to build 20 driverless trucks per week in Q4 and is fully allocated for 2026, with revenue guidance of $14–16 million. This shows the company can scale manufacturing, a key step toward its 200-truck year-end goal and future growth.

    It gives concrete evidence of manufacturing scale-up, which underpins the growth story.

  • Investor Day 2030 targets and analyst split Aurora set 2030 goals of 30,000 driverless trucks and $5 billion revenue at 60% gross margin, but pushed breakeven gross margin to H1 2027. Analysts' price targets range from $7 to $18, with Goldman cautious on a slower, costlier ramp. The long-term vision is huge, but near-term cash burn and execution risk keep the stock volatile.

    It captures both the ambitious long-term plan and the real counterweight of execution and cash concerns.